You are using an unsupported browser. Please use the latest version of Chrome, Firefox, Safari or Edge.
The one hundred honoree: Patricia M. LoRusso, DO

Innovation Story

The one hundred honoree: Patricia M. LoRusso, DO

Mass General Giving

Patricia LoRusso, DO, is an exemplar and respected advocate of translational therapeutics for cancer. A 1981 Michigan State University College of Osteopathic Medicine graduate, she now serves as professor of Oncology at the Wayne State University School of Medicine and the director of the Eisenberg Center for Translational Therapeutics at the Karmanos Cancer Institute, Detroit, Michigan. She currently is the principal investigator of one of 10 UM1 Early Therapeutics grants with the National Cancer Institute and is the co-leader of the Melanoma Dream Team, funded through a partnership between Stand Up To Cancer and the Melanoma Research Alliance. Her oncology focus has been early therapeutics and innovative clinical trial designs, and she has been integrally involved in the early development of many anti-cancer agents that are now FDA approved for commercial use.

Dr. LoRusso has published a plethora of peer-reviewed publications, abstracts and book chapters. She has secured multiple grants and contracts during her academic tenure. She has garnered numerous significant achievements in professional and scientific organizations, scholarly service, teaching and consultation. She has been integrally involved in a wide range of scholarly organizations including the National Cancer Institute Cancer Therapy Evaluation Program and affiliate committees, American Society of Clinical Oncology, American Association for Cancer Research and many others.

Dr. LoRusso’s greatest accomplishment is her focus on improving outcomes for her patients. A tireless advocate for her patients, her primary goal is to define better therapeutic interventions so as to improve their lives, both in duration and quality, in hopes of redefining their focus from “the patient” to “the person.” She leads a team of dedicated individuals who have joined together to help make that difference so needed in clinical oncology.